Sobi to acquire Arthrosi Therapeutics, strengthening pipeline for the potential treatment of gout
Prnewswire·2025-12-14 04:57
The transaction is subject to the satisfaction of customary closing conditions and is expected to close in H1 2026. Sobi plans to fund the upfront payment mainly through debt in the form of existing credit facilities and a new credit facility provided by Handelsbanken and Danske Bank. The acquisition is expected to be highly accretive to Sobi's mid- to long-term growth and margin trajectory. Barclays Bank PLC is acting as Sobi's financial advisor and McDermott, Will & Schulte is acting as legal advisor to S ...